Multifocal Choroiditis: Clinical Trials

1 trial for Multifocal Choroiditis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 withdrawn. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Withdrawn 1

Follow Multifocal Choroiditis: new trials by email Literature Review of Multifocal Choroiditis trials Research Report on Multifocal Choroiditis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD
Bevacizumab (Avastin; Genentech, Inc.), Bevacizumab, Dexamethasone, Verteporfin Photodynamic Therapy - Choroidal Neovascularization, Myopia
Not applicableWithdrawnMassachusetts Eye and Ear Infirmary2010-08-012014-01-14

Narrower conditions

Angioid Streaks (1)  ·  Central Serous Chorioretinopathy (1)  ·  Choroidal Neovascularization (1)  ·  Eye Diseases, Hereditary (1)  ·  Myopia (1)  ·  White Dot Syndromes (1)  ·  Wounds and Injuries (1)

Broader conditions

Choroid Diseases (1)  ·  Choroiditis (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Eye Diseases (1)  ·  Genetic Diseases, Inborn (1)  ·  Metaplasia (1)  ·  Neovascularization, Pathologic (1)  ·  Panuveitis (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Refractive Errors (1)  ·  Retinal Diseases (1)  ·  Uveal Diseases (1)  ·  Uveitis (1)  ·  Uveitis, Posterior (1)

Interventions

Bevacizumab (1)  ·  Dexamethasone (1)

Sponsors

Massachusetts Eye and Ear Infirmary (1)

Top investigators

Ivana K Kim, MD (1)

Results publications

PMID 40522203